SCHEMBL6533276

SCHEMBL6533276

CCCCCNC(C)(C)CCn1c(=O)c2c(C)n(C3CCCCO3)nc2c2cc(Cl)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 7/20 0.38
CHEK1 O14757 3/20 0.37
RORA P35398 1/20 0.33
RORC P51449 1/20 0.33
NR1H2 P55055 1/20 0.33
RORB Q92753 1/20 0.33
KCNH2 Q12809 1/20 0.32
MCHR1 Q99705 1/20 0.32
GSK3B P49841 4/20 0.32
KDM4E B2RXH2 2/20 0.31
HSD17B10 Q99714 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6525478 0.87 CHEK1 (0.36) CNR2CHEK1
SCHEMBL6516690 0.85 CHEK1 (0.42) CNR2CHEK1KCNH2KDM4EHSD17B10
SCHEMBL6511027 0.80 ATR (0.42) CNR2CHEK1
SCHEMBL6511094 0.80 CHEK1 (0.41) CNR2CHEK1KDM4EHSD17B10NPSR1
SCHEMBL6522000 0.79 CHEK1 (0.41) CNR2CHEK1KDM4EHSD17B10ALDH1A1
SCHEMBL6514165 0.78 CHEK1 (0.39) CNR2CHEK1KDM4EHSD17B10NPSR1
SCHEMBL6514903 0.78 HTR2C (0.37) CNR2CHEK1RORARORCNR1H2
SCHEMBL6515376 0.78 MAPT (0.41) CNR2CHEK1LMNAMAPT
SCHEMBL6511866 0.77 CHEK1 (0.38) CNR2CHEK1KDM4EHSD17B10ALDH1A1
SCHEMBL6522817 0.77 CHEK1 (0.39) CNR2CHEK1KDM4EHSD17B10NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005028474-A2 PYRAZOLOQUINOLINE DERIVATIVES AS CHK-1 INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2005-03-31 WO disclosed